Literature DB >> 19318651

Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.

Jean-François Timsit1, Carole Schwebel, Lila Bouadma, Arnaud Geffroy, Maïté Garrouste-Orgeas, Sebastian Pease, Marie-Christine Herault, Hakim Haouache, Silvia Calvino-Gunther, Brieuc Gestin, Laurence Armand-Lefevre, Véronique Leflon, Chantal Chaplain, Adel Benali, Adrien Francais, Christophe Adrie, Jean-Ralph Zahar, Marie Thuong, Xavier Arrault, Jacques Croize, Jean-Christophe Lucet.   

Abstract

CONTEXT: Use of a chlorhexidine gluconate-impregnated sponge (CHGIS) in intravascular catheter dressings may reduce catheter-related infections (CRIs). Changing catheter dressings every 3 days may be more frequent than necessary.
OBJECTIVE: To assess superiority of CHGIS dressings regarding the rate of major CRIs (clinical sepsis with or without bloodstream infection) and noninferiority (less than 3% colonization-rate increase) of 7-day vs 3-day dressing changes. DESIGN, SETTING, AND PATIENTS: Assessor-blind, 2 x 2 factorial, randomized controlled trial conducted from December 2006 through June 2008 and recruiting patients from 7 intensive care units in 3 university and 2 general hospitals in France. Patients were adults (>18 years) expected to require an arterial catheter, central-vein catheter, or both inserted for 48 hours or longer.
INTERVENTIONS: Use of CHGIS vs standard dressings (controls). Scheduled change of unsoiled adherent dressings every 3 vs every 7 days, with immediate change of any soiled or leaking dressings. MAIN OUTCOME MEASURES: Major CRIs for comparison of CHGIS vs control dressings; colonization rate for comparison of 3- vs 7-day dressing changes.
RESULTS: Of 2095 eligible patients, 1636 (3778 catheters, 28,931 catheter-days) could be evaluated. The median duration of catheter insertion was 6 (interquartile range [IQR], 4-10) days. There was no interaction between the interventions. Use of CHGIS dressings decreased the rates of major CRIs (10/1953 [0.5%], 0.6 per 1000 catheter-days vs 19/1825 [1.1%], 1.4 per 1000 catheter-days; hazard ratio [HR], 0.39 [95% confidence interval {CI}, 0.17-0.93]; P = .03) and catheter-related bloodstream infections (6/1953 catheters, 0.40 per 1000 catheter-days vs 17/1825 catheters, 1.3 per 1000 catheter-days; HR, 0.24 [95% CI, 0.09-0.65]). Use of CHGIS dressings was not associated with greater resistance of bacteria in skin samples at catheter removal. Severe CHGIS-associated contact dermatitis occurred in 8 patients (5.3 per 1000 catheters). Use of CHGIS dressings prevented 1 major CRI per 117 catheters. Catheter colonization rates were 142 of 1657 catheters (7.8%) in the 3-day group (10.4 per 1000 catheter-days) and 168 of 1828 catheters (8.6%) in the 7-day group (11.0 per 1000 catheter-days), a mean absolute difference of 0.8% (95% CI, -1.78% to 2.15%) (HR, 0.99; 95% CI, 0.77-1.28), indicating noninferiority of 7-day changes. The median number of dressing changes per catheter was 4 (IQR, 3-6) in the 3-day group and 3 (IQR, 2-5) in the 7-day group (P < .001).
CONCLUSIONS: Use of CHGIS dressings with intravascular catheters in the intensive care unit reduced risk of infection even when background infection rates were low. Reducing the frequency of changing unsoiled adherent dressings from every 3 days to every 7 days modestly reduces the total number of dressing changes and appears safe. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00417235.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318651     DOI: 10.1001/jama.2009.376

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  100 in total

Review 1.  Healthcare-associated infection prevention in pediatric intensive care units: a review.

Authors:  N Joram; L de Saint Blanquat; D Stamm; E Launay; C Gras-Le Guen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-01       Impact factor: 3.267

Review 2.  [Results of studies in critical care medicine in the year 2009 : update].

Authors:  M Bernhard; G Marx; K Weismüller; C Lichtenstern; K Mayer; F M Brunkhorst; M A Weigand
Journal:  Anaesthesist       Date:  2010-05       Impact factor: 1.041

3.  A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis.

Authors:  Bernard C Camins; Amy M Richmond; Kathrin L Dyer; Heather N Zimmerman; Daniel W Coyne; Marcos Rothstein; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

4.  Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing.

Authors:  S Scheithauer; K Lewalter; J Schröder; A Koch; H Häfner; V Krizanovic; K Nowicki; R-D Hilgers; S W Lemmen
Journal:  Infection       Date:  2013-08-09       Impact factor: 3.553

5.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

6.  National estimates of central line-associated bloodstream infections in critical care patients.

Authors:  Matthew E Wise; R Douglas Scott; James M Baggs; Jonathan R Edwards; Katherine D Ellingson; Scott K Fridkin; L Clifford McDonald; John A Jernigan
Journal:  Infect Control Hosp Epidemiol       Date:  2013-04-18       Impact factor: 3.254

7.  Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

Authors:  Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint
Journal:  Clin Infect Dis       Date:  2011-05       Impact factor: 9.079

Review 8.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

9.  Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology for venous catheter placement and maintenance.

Authors:  Donald L Miller; Naomi P O'Grady
Journal:  J Vasc Interv Radiol       Date:  2012-08       Impact factor: 3.464

10.  Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction.

Authors:  Amy C Degnim; Tanya L Hoskin; Rushin D Brahmbhatt; Anne Warren-Peled; Margie Loprinzi; Emily S Pavey; Judy C Boughey; Tina J Hieken; Steven Jacobson; Valerie Lemaine; James W Jakub; Chetan Irwin; Robert D Foster; Hani Sbitany; Michel Saint-Cyr; Erin Duralde; Sheri Ramaker; Robin Chin; Monica Sieg; Melissa Wildeman; Jeffrey S Scow; Robin Patel; Karla Ballman; Larry M Baddour; Laura J Esserman
Journal:  Ann Surg Oncol       Date:  2014-08-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.